Sex hormone receptor binding, progestin selectivity, and the new oral contraceptives
- 1 May 1994
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 170 (5) , 1508-1513
- https://doi.org/10.1016/s0002-9378(12)91808-6
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Preclinical evaluation of norgestimate, a progestin with minimal androgenic activityAmerican Journal of Obstetrics and Gynecology, 1992
- Pharmacokinetics of oestrogens and progestogensMaturitas, 1990
- Progestational and androgenic receptor binding affinities and in vivo activities of norgestimate and other progestinsContraception, 1990
- Effects of 180 μg and 250 μg norgestimate on pituitary-ovarian function and cervical mucusFertility and Sterility, 1988
- Selectivity in progesterone and androgen receptor binding of progestagens used in oral contraceptivesContraception, 1988
- The influence of structural modification on progesterone and androgen receptor binding of norethisterone. Correlation with nuclear magnetic resonance signalsActa Endocrinologica, 1987
- Binding of progestagens to receptor proteins in MCF-7 cellsThe Journal of Steroid Biochemistry and Molecular Biology, 1983
- Binding of a contraceptive progestogen Org 2969 and its metabolites to receptor proteins and human sex hormone binding globulinJournal of Steroid Biochemistry, 1981
- Ovulation Inhibition with Different Doses of Levonorgestrel and Other Progestogens: Clinical and Experimental InvestigationsActa Obstetricia et Gynecologica Scandinavica, 1979
- The influence on the pituitary-ovarian function, cervical mucus and vaginal cytology of a new progestational compoundContraception, 1976